Study into conolidine has led to discovery of an opioid receptor in the body known as ACKR3/CXCR7. ACKR3 appears to be by far the most desired target for conolidine, which also disregards the opposite 4 classical opioid receptors(3). This exclusive mechanism boosts the body’s natural pain relief method, featuring https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers